PharmaCyte Biotech Ownership | Who Owns PharmaCyte Biotech?

PharmaCyte Biotech Ownership Summary

PharmaCyte Biotech is owned by 4.18% institutional investors, 10.64% insiders, and 85.18% retail investors. Geode capital management is the largest institutional shareholder, holding 1.86% of PMCB shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.71% of its assets in PharmaCyte Biotech shares.

PMCB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	PharmaCyte Biotech	4.18%	10.64%	85.18%
Sector	Healthcare Stocks	42.53%	10.81%	46.67%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Geode capital management	126.60K	1.86%	$122.77K
Renaissance	80.00K	1.18%	$77.57K
Vanguard group	74.92K	1.10%	$72.67K
Equitec proprietary markets	82.73K	1.08%	$129.88K
Susquehanna group, llp	34.48K	0.45%	$53.45K
Schonfeld strategic advisors	26.20K	0.39%	$25.40K
Northern trust	19.21K	0.28%	$18.62K
Blackrock	13.35K	0.16%	$26.16K
Tower research capital llc (trc)	5.55K	0.08%	$5.38K
Ubs group	1.32K	0.02%	$1.28K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Equitec proprietary markets	82.73K	0.13%	$129.88K
Tower research capital llc (trc)	5.55K	0.00%	$5.38K
Schonfeld strategic advisors	26.20K	0.00%	$25.40K
Planning capital management	100.00	0.00%	$196.00
Renaissance	80.00K	0.00%	$77.57K
Cwm	-	-	-
Blackrock	13.35K	-	$26.16K
Susquehanna group, llp	34.48K	-	$53.45K
Advisor group	304.00	-	$294.00
Two sigma securities	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Renaissance	80.00K	0.00%	30.20K
Tower research capital llc (trc)	5.55K	0.00%	2.77K
Simplex trading	1.10K	-	1.10K
Planning capital management	100.00	0.00%	100.00
Bank of america corp /de/	152.00	-	98.00

Top Sellers

Holder	Shares	% Assets	Change
K2 principal fund	-	-	-209.27K
Vanguard group	74.92K	-	-119.53K
Two sigma securities	-	-	-27.75K
Ubs group	1.32K	-	-21.27K
Dimensional fund advisors lp	-	-	-20.30K

New Positions

Holder	Shares	% Assets	Change	Value
Simplex trading	1.10K	-	1.10K	$1.00K
Planning capital management	100.00	0.00%	100.00	$196.00
Accredited wealth management	50.00	-	50.00	$1.00K
Financial consulate	2.00	-	2.00	$2.00
Citigroup	1.00	-	1.00	$1.00

Sold Out

Holder	Change
Koesten, hirschmann & crabtree	-1.00
Jones financial companies lllp	-2.00
Jpmorgan chase	-16.00
Maryland capital advisors	-35.00
Park square financial group	-37.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	11	-45.00%	284,018	-50.74%	4	5.81%	6	-25.00%	2	-33.33%
Jun 30, 2025	21	-12.50%	576,457	1.50%	8	12.74%	8	-	3	-66.67%
Mar 31, 2025	24	20.00%	567,926	-5.40%	8	13.20%	8	300.00%	9	12.50%
Dec 31, 2024	9	-60.87%	516,536	-37.46%	6	6.14%	-	-100.00%	3	-66.67%
Sep 30, 2024	23	-8.00%	825,885	-19.96%	10	7.30%	5	-58.33%	9	28.57%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	117.47K	1.71%	-
Vanguard Total Stock Mkt Idx Inv	95.07K	1.40%	-24.46K
Vanguard Institutional Extnd Mkt Idx Tr	51.47K	0.76%	-23.45K
Fidelity Extended Market Index	41.70K	0.61%	-294.00
Fidelity Nasdaq Composite Index	26.21K	0.39%	-
Spartan Total Market Index Pool G	20.06K	0.30%	-
Spartan Total Market Index Pool E	20.06K	0.29%	-
Fidelity Total Market Index	15.26K	0.22%	-
NT Ext Equity Mkt Idx Fd - NL	14.43K	0.21%	-
Fidelity Series Total Market Index	12.90K	0.19%	-

Insider Transactions Trends

Date	Buy	Sell
2023 Q4	-	-
2022 Q4	-	-
2022 Q3	-	-
2022 Q1	-	-
2021 Q3	-	-

PMCB Ownership FAQ

Who Owns PharmaCyte Biotech?

PharmaCyte Biotech shareholders are primarily institutional investors at 4.18%, followed by 10.64% insiders and 85.18% retail investors. The average institutional ownership in PharmaCyte Biotech's industry, Biotech Stocks , is 45.24%, which PharmaCyte Biotech falls below.

Who owns the most shares of PharmaCyte Biotech?

PharmaCyte Biotech’s largest shareholders are Geode capital management (126.6K shares, 1.86%), Renaissance (80K shares, 1.18%), and Vanguard group (74.92K shares, 1.10%). Together, they hold 4.14% of PharmaCyte Biotech’s total shares outstanding.

Does Blackrock own PharmaCyte Biotech?

Yes, BlackRock owns 0.16% of PharmaCyte Biotech, totaling 13.35K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 26.16K$. In the last quarter, BlackRock decreased its holdings by -7.758K shares, a -36.76% change.

Who is PharmaCyte Biotech’s biggest shareholder by percentage of total assets invested?

Equitec proprietary markets is PharmaCyte Biotech’s biggest shareholder by percentage of total assets invested, with 0.13% of its assets in 82.73K PharmaCyte Biotech shares, valued at 129.88K$.

Who is the top mutual fund holder of PharmaCyte Biotech shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of PharmaCyte Biotech shares, with 1.71% of its total shares outstanding invested in 117.47K PharmaCyte Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools